Articles tagged with Pluripotent Stem Cells
Researchers at UCLA successfully reprogrammed normal tissue cells into cells with unlimited properties as embryonic stem cells, offering a promising alternative to current cloning methods. The breakthrough could lead to the creation of immune-compatible cells for disease treatment and regenerative therapies.
Researchers successfully induced pluripotent cells from fibroblasts using four transcription factors, exhibiting properties similar to embryonic stem cells. These findings have significant implications for regenerative medicine and may pave the way for generating patient-specific stem cell lines directly from a person's own cells.
Researchers have successfully induced differentiated adult cells to behave like embryonic stem cells using only four factors. This breakthrough enables the creation of pluripotent cells directly from a patient's own cells, potentially revolutionizing the treatment of diseases such as Parkinson's disease and diabetes.
Researchers have successfully induced differentiated adult cells to behave like embryonic stem cells using only four factors. The discovery could revolutionize the treatment of diseases such as Parkinson's and diabetes by providing a direct source of pluripotent cells from patients' own cells.
Researchers from Gladstone Institutes have gained a better understanding of the use of stem cells to generate replacement cells for damaged heart muscle and vessels. The study highlights several challenges ahead, including guiding stem cells into cardiac lineage and integrating them safely within patients' heart tissue.
A team of researchers has identified three key transcription factors that enable human embryonic stem cells to maintain pluripotency. By understanding the regulatory circuitry controlling these cells, scientists can now develop strategies to coax them into specific cell types for regenerative medicine applications.
Researchers have successfully used human muscle-derived stem cells to restore leak-point pressure in animal models of stress urinary incontinence. The therapy involves injecting the cells into the periurethral muscle, which differentiates into new muscle fibers to prevent atrophy. Clinical trials are underway in Toronto.
Researchers discovered that Sox2 is a crucial transcription factor involved in the specification of three embryonic cell lineages. The study found that Sox2-deficient embryos exhibit fatal defects, highlighting its importance in maintaining cellular pluripotency and embryo formation.
Researchers discovered Foxd3 as a crucial gene regulating embryonic stem cell fate and pluripotency. The gene is required for normal embryonic development, including the formation of inner cell mass and extraembryonic tissues.
Researchers have identified a molecule, GCNF, that restricts mouse cells' potency. This discovery may allow for the creation of embryonic stem cells without sacrificing embryos, opening up new avenues for research.
Researchers investigate integrin signaling in psoriasis, discovering altered expression of key proteins involved in immune responses. This study sheds light on potential therapeutic targets for treatment of the chronic skin condition.